Literature DB >> 10510282

Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease.

R L Russell1, S L Siedlak, A K Raina, J M Bautista, M A Smith, G Perry.   

Abstract

We analyzed glucose-6-phosphate dehydrogenase, the rate-controlling enzyme of the pentose phosphate pathway and free sulfhydryls, to study redox balance in Alzheimer disease. Glucose-6-phosphate dehydrogenase plays a pivotal role in homeostatic redox control by providing reducing equivalents to glutathione, the major nonenzymatic cellular antioxidant. There is a multitude of evidence that marks oxidative stress proximally in the natural history of Alzheimer disease. Consistent with a role for glutathione in defense against increased reactive oxygen, we found an upregulation of glucose-6-phosphate dehydrogenase together with increased sulfhydryls in Alzheimer disease. These data indicate that reductive compensation may play an important role in combating oxidative stress in Alzheimer disease. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510282     DOI: 10.1006/abbi.1999.1404

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  35 in total

1.  Multidirectional inhibition of cortico-hippocampal neurodegeneration by kolaviron treatment in rats.

Authors:  Olayemi Joseph Olajide; Nnaemeka Tobechukwu Asogwa; Blessing Oluwapelumi Moses; Christiana Bidemi Oyegbola
Journal:  Metab Brain Dis       Date:  2017-04-13       Impact factor: 3.584

Review 2.  Disturbance of redox homeostasis as a contributing underlying pathomechanism of brain and liver alterations in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.

Authors:  Guilhian Leipnitz; Carmen Regla Vargas; Moacir Wajner
Journal:  J Inherit Metab Dis       Date:  2015-06-04       Impact factor: 4.982

3.  The role of glucose-6-phosphate dehydrogenase in adipose tissue inflammation in obesity.

Authors:  Yoon Jeong Park; Sung Sik Choe; Jee Hyung Sohn; Jae Bum Kim
Journal:  Adipocyte       Date:  2017-02-08       Impact factor: 4.534

Review 4.  Membrane Aging as the Real Culprit of Alzheimer's Disease: Modification of a Hypothesis.

Authors:  Qiujian Yu; Chunjiu Zhong
Journal:  Neurosci Bull       Date:  2017-11-24       Impact factor: 5.203

Review 5.  Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Authors:  B Halliwell
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 6.  Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies.

Authors:  Michael W Marlatt; Paul J Lucassen; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

7.  Oxidative stress in the progression of Alzheimer disease in the frontal cortex.

Authors:  Mubeen A Ansari; Stephen W Scheff
Journal:  J Neuropathol Exp Neurol       Date:  2010-02       Impact factor: 3.685

8.  Treatment advances in Alzheimer's disease based on the oxidative stress model.

Authors:  Avi L Friedlich; Raj K Rolston; Xiongwei Zhu; Michael W Marlatt; Rudy J Castellani; Akihiko Nunomura; Hyoung-Gon Lee; Gemma Casadesus; George Perry; Mark A Smith
Journal:  F1000 Med Rep       Date:  2009-07-08

9.  Ablation of the locus coeruleus increases oxidative stress in tg-2576 transgenic but not wild-type mice.

Authors:  Orest Hurko; Kurt Boudonck; Cathleen Gonzales; Zoe A Hughes; J Steve Jacobsen; Peter H Reinhart; Daniel Crowther
Journal:  Int J Alzheimers Dis       Date:  2010-10-11

10.  Brain glucose-6-phosphate dehydrogenase protects against endogenous oxidative DNA damage and neurodegeneration in aged mice.

Authors:  Winnie Jeng; Margaret M Loniewska; Peter G Wells
Journal:  ACS Chem Neurosci       Date:  2013-05-14       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.